companies / biospyder-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-17 json
| total_raised | 2,638,5302.6M | ○ |
|---|---|---|
| founded | null | |
| hq | Carlsbad, California, USA | |
| industry | unknown | |
| stage | null |
BioSpyder runs the TempO-Seq targeted-sequencing platform, profiling hundreds to thousands of genes across many samples by ligating template-dependent oligo barcodes. It is used by toxicology, oncology, and pharma teams running compound screening and translational studies. Multiplexes up to 6,144 samples per run with under one hour of hands-on time, no full DNA conversion.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2023-09-01 | grant | 2,600,0002.6M | null | ○ |
Typekit, Adobe Fonts, Afterpay, Sentry, Spin.js, Squarespace, Squarespace Commerce, Stimulus, web-vitals, moment 0, @sentry/browser
| fact | status | src |
|---|---|---|
| Grant, $2.6M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |